Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Stock Tracker

This tool allows subscribers to track the progress of share prices belonging to all of the key listed animal health companies.

Zoetis to discontinue sales of equine wormer

Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.

United Kingdom Antiparasitics

Macdonald moves from Virbac to Zoetis in New Zealand

Vanessa Macdonald has become the general manager of Zoetis' business branch in New Zealand.

Zoetis People

Smart Flow cloud technology joins IDEXX

IDEXX Laboratories has expanded its veterinary cloud portfolio with the addition of a new clinical workflow system.

IDEXX Laboratories Equipment & Technology

Anatara defends Zoetis deal as shares sink

Australian firm Anatara Lifesciences has addressed its recent share price slump, which it has linked to a development deal with Zoetis.

Deals Zoetis

KindredBio becomes commercial entity as Mirataz goes on sale

US pet therapeutics company Kindred Biosciences has become a commercial entity around six years after it was founded.

United States Kindred Biosciences

Zoetis gets first clearance for Abaxis acquisition

Zoetis' acquisition of Abaxis has now been cleared under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act).

Zoetis Abaxis
See All